🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies molecular profiling-based assignment of cancer ...
Status
Completed
Location
University of Colorado Hospital
Start Date
2014-01-07
Trial ID
NCT01827384
Treatments Being Tested
The purpose of this study is to determine if patients with p53 mutated epit...
Status
Completed
Location
FL Opdam
Start Date
2010-07
Trial ID
NCT01164995
Treatments Being Tested
This is a study of the safety and efficacy of adavosertib in combination wi...
Status
Completed
Location
Multiple Locations
Start Date
2011-07-26
Trial ID
NCT01357161
Treatments Being Tested
The aim of this study is to combine AZD1775 with standard front-line chemot...
Status
Terminated
Location
Research Site
Start Date
2014-03
Trial ID
NCT02087241
Treatments Being Tested
This proof-of-concept platform trial is designed to cover the targeting of ...
Status
Recruiting
Location
Rigshospitalet
Start Date
2016-08-03
Trial ID
NCT02813135
This is a phase Ib, open-label, multicentre study of AZD1775 administered o...
Status
Completed
Location
Research Site
Start Date
2015-01-16
Trial ID
NCT02341456
Treatments Being Tested
The purpose of this study is to find out what effects (good and bad) AZD177...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2015-10-13
Trial ID
NCT02513563
Treatments Being Tested
Adavosertib in combination with carboplatin, paclitaxel, gemcitabine, or PL...
Status
Completed
Location
Research Site
Start Date
2015-01-30
Trial ID
NCT02272790
Treatments Being Tested
Study design This is a Phase II, open-label, multi-drug, multi-center, mult...
Status
Completed
Location
Research Site
Start Date
2016-11-28
Trial ID
NCT02937818
Treatments Being Tested
This study will investigate the safety, tolerability, pharmacokinetic (PK),...
Status
Completed
Location
Multiple Locations
Start Date
2008-02-25
Trial ID
NCT00648648
Treatments Being Tested